Literature DB >> 11489330

Transport and absorption of drugs via the lymphatic system.

C J Porter1, W N Charman.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11489330     DOI： 10.1016/s0169-409x(01)00146-6

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


× No keyword cloud information.
  5 in total

1.  Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.

Authors:  Jeffrey M Jacobson; Melanie A Thompson; Jacob P Lalezari; Michael S Saag; Barry S Zingman; Paul D'Ambrosio; Nancy Stambler; Yakov Rotshteyn; Andre J Marozsan; Paul J Maddon; Stephen A Morris; William C Olson
Journal:  J Infect Dis       Date:  2010-05-15       Impact factor: 5.226

2.  Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration.

Authors:  Yanan Zheng; Devin B Tesar; Lisa Benincosa; Herbert Birnböck; C Andrew Boswell; Daniela Bumbaca; Kyra J Cowan; Dimitry M Danilenko; Ann L Daugherty; Paul J Fielder; Hans Peter Grimm; Amita Joshi; Nicole Justies; Gerry Kolaitis; Nicholas Lewin-Koh; Jing Li; Sami McVay; Jennifer O'Mahony; Michael Otteneder; Michael Pantze; Wendy S Putnam; Zhihua J Qiu; Jane Ruppel; Thomas Singer; Oliver Stauch; Frank-Peter Theil; Jennifer Visich; Jihong Yang; Yong Ying; Leslie A Khawli; Wolfgang F Richter
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

Review 3.  Nanomedicine for increasing the oral bioavailability of cancer treatments.

Authors:  Alessandro Parodi; Polina Buzaeva; Daria Nigovora; Alexey Baldin; Dmitry Kostyushev; Vladimir Chulanov; Lyudmila V Savvateeva; Andrey A Zamyatnin
Journal:  J Nanobiotechnology       Date:  2021-10-30       Impact factor: 10.435

Review 4.  Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases.

Authors:  Michela Flego; Alessandro Ascione; Maurizio Cianfriglia; Stefano Vella
Journal:  BMC Med       Date:  2013-01-04       Impact factor: 8.775

Review 5.  Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development.

Authors:  Jay Tibbitts; David Canter; Ryan Graff; Alison Smith; Leslie A Khawli
Journal:  MAbs       Date:  2015-12-04       Impact factor: 5.857
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.